Company intelligence / Profile preview

Research Institute of Atomic Reactors

Dimitrovgrad, Ulyanovsk Oblast, Russia

Ownership: Private
Development stage: Other

Overview

RIAR is Russia's largest experimental nuclear power research complex specializing in nuclear materials testing, developing innovative reactor and fuel technologies, and manufacturing radioisotopes for science, industry, and medicine; it is recognized as a key site for international research collaboration including nuclear medicine and the production of ionizing radiation sources[1][4].

Therapeutic areas: OncologyOther
Modalities: RadiopharmaceuticalDevice (radiation sources)
Industry: Chemicals & Materials

Partnerships

Rosatom (parent and strategic partner for all activities)IAEA (International Atomic Energy Agency—RIAR is an IAEA ICERR international center)[5][8]Collaborations with Generation IV International Forum participants

Beyond the preview

Go deeper on Research Institute of Atomic Reactors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Research Institute of Atomic Reactors.

Explore the full profile